HIV/AIDS Diagnostics
Rapid and standard HIV Ab ELISAs negatively affected by HIV-indeterminates
Published in AIDS Weekly, March 14th, 2005
"The performance of 4 rapid and simple assays: Camstix-HIV 1+2 (Camdiagnostix, Yaounde, Cameroon); Determine HIV 1+2+0 (Abbott Laboratories, Tokyo, Japan); Genie II HIV-1/HIV-2 (Bio-Rad, Marnes la Coquette, France); ImmunoComb II HIV 1 & 2 BiSpot (Orgenics, Yavne, Israel); and 2 fourth-generation ELISAs: Enzygnost HIV Integral (Dade Behring, Marburg, Germany) and Genscreen plus HIV Ag-Ab (Bio-Rad, Marries la Coquette, France) currently used in Cameroon to detect HIV infections were evaluated on a local serum panel.
"A total of 503 samples were collected, using the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-03-14)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
Homeless in San Francisco HIV seroconversion incidence/risk factors estimated - HIV/AIDS Prevention
Antiretrovirals to prevent vertical transmission protects against infant anemia - HIV/AIDS Therapy
Nelfinavir induces adipocyte necrosis by oxidative stress - HIV/AIDS Transmission
Micronutrient supplementation increases genital tract shedding of HIV-1 in women - Allergy and Immunology
Thymalfasin shows promise for treating viral hepatitis and cancer - Antiviral Therapy
Topical gel inhibits HIV and HSV infection in cervicovaginal lavage fluid - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
